Sudhen B. Desai, Robert J. Lewandowski and Albert A. Nemcek, Jr. Indications for percutaneous biopsy are to (1) establish a malignant diagnosis, (2) establish a benign diagnosis, and (3) obtain material for culture or other laboratory studies. Departmental review of patient selection should be undertaken if less than 95% of image-guided percutaneous biopsies are being performed for these three indications.1 Additionally, it should be requisite that plans for treatment or further investigation will be strongly influenced by the biopsy results. Relative contraindications to biopsy of a lesion include: • Coagulopathy (prothrombin time > 15 seconds; platelets < 50,000; patient not withdrawn from anticoagulation for a safe period, e.g., 4 hours for heparin and 7 days for warfarin [Coumadin], clopidogrel [Plavix], and nonsteroidal antiinflammatory drugs [NSAIDs]) • Unsafe target for biopsy (e.g., highly vascular tumor) • Absence of a safe pathway from the skin to the target site. Consideration should be given to use of other imaging modalities (e.g., ultrasound vs. computed tomography [CT] guidance) or other sites of access (e.g., percutaneous vs. transjugular hepatic biopsy). Each imaging modality has relative advantages and disadvantages (Table 126-1), so certain situations may favor the use of specific modalities. Mobile lesions and lesions that require multiple imaging angles, for example, may be better suited to ultrasound-guided biopsy (Fig. 126-1). Deeper lesions that might be obscured by bowel gas or limited by body habitus may be easier to biopsy under CT guidance. TABLE 126-1 Comparison of Imaging Modalities for Biopsy
Percutaneous Biopsy
Indications
Contraindications
Technique
Advantages
Disadvantages
CT
Can be time consuming
Certain imaging planes (e.g., craniocaudal) may be difficult to obtain.
Opportunity and cost (diagnostic evaluations vs. interventions on the scanner)
Radiation exposure
Ultrasound
Inadequate visualization of the target or needle (operator dependent or limited by habitus, bowel gas, fibrous scarring, bony structures, lesion depth)
Fluoroscopy
Radiation exposure
Single-dimension imaging
Not portable
CT fluoroscopy
? Impact on time, patient outcomes, radiation exposure
MRI
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access